Optimization of codon usage of the envelope protein E2 gene from various genotypes of hepatitis C virus to predict the expression level in Pichia pastoris

다국어 초록 (Multilingual Abstract)

Hepatitis C virus infection (HCV) alarmingly increases worldwide; it causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma, so there is urgent need of developing effective and sufficient quantity of vaccine.
HCV envelope protein E2 is the main target for developing as a vaccine candidate. Presently recombinant proteins can successfully be used as a vaccine for many diseases. This concern, it is challenging to produce sufficient quantities of many recombinant proteins from their expression hosts.
One of the main factors affecting the success of expression of foreign genes in heterologous hosts is the divergence of codon usage of the target gene from that used in the expression system. In this study, we optimized the various genotypes of HCV envelope protein E2 gene according to the codon usage of Pichia pastoris and predicted the expression level. Synonymous codon usage of E2 adapted to that used by P. pastoris was estimated using the relative synonymous codon usage value (RSCU), codon adaptation index (CAI) and effective number of codon (ENC). The CAI of optimized HCV E2 sequences was enhanced from 0.638 to 0.833 and %GC was decreased from 56.05 to 44.05; this was significantly (p\0.01) different from the native sequences. Codon with RSCU value less than one was replaced with most preferred synonymous codons. The ENC values of optimized HCV E2 sequences varied from 47.00 to 47.50, with a mean value of 47.15 and an SD of 0.14. Our study suggested that, from the measured values of predicted expression level, the codon optimized HCV E2 protein could be produced in sufficient quantity in the expression host; knowledge of the codon usage patterns of E2 of various genotypes facilitate the production of a promising unique vaccine candidate for HCV.

참고문헌 (Reference)

1 McCaffrey K, "The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity" 92 : 112-121, 2011

2 Sharp PM, "The codon adaptation index—a measure of directional synonymous codon usage bias, and its potential applications" 15 : 1281-1295, 1987

3 Sinclair G, "Synonymous codon usage bias and the expression of human glucocerebrosidase in the methylotrophic yeast Pichia pastoris" 26 : 96-105, 2002

4 Cregg JM, "Recent advances in the expression of foreign genes in Pichia pastoris" 11 : 905-910, 1993

5 Wan XF, "Quantitative relationship between synonymous codon usage bias and GC composition across unicellular genomes" 4 : 19-, 2004

6 Liu WJ, "Polynucleotide viral vaccines: codon optimisationand ubiquitin conjugation enhances prophylactic and therapeutic efficacy" 20 : 862-869, 2001

7 Uchijima M, "Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium" 161 : 5594-5599, 1998

8 Puigbo P, "OPTIMIZER: a web server for optimizing the codon usage of DNA sequences" 35 : 126-131, 2007

9 Faber KN, "Methylotrophic yeasts as factories for the production of foreign proteins" 11 : 1331-1344, 1995

10 Choo QL, "Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome" 244 : 359-362, 1989

11 Carlini DB, "In vivo introduction of unpreferred synonymous codons into the Drosophila Adh gene results in reduced levels of ADH protein" 163 : 239-243, 2003

12 Macauley-Patrick S, "Heterologous protein production using the Pichia pastoris expression system" 22 : 249-270, 2005

13 Dubuisson J, "Hepatitis C virus glycoprotein folding: disulfide bond formation and association with calnexin" 70 : 778-786, 1996

14 Machida K, "Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells" 79 : 8079-8089, 2005

15 Villalobos A, "Gene designer: a synthetic biology tool for constructing artificial DNA segments" 7 : 285-, 2006

16 Lindenbach BD, "Fields virology" Lippincott-Raven 991-1041, 2001

17 Li YP, "Elicitation of strong immune responses by a DNA vaccine expressing a secreted form of hepatitis C virus envelope protein E2 in murine and porcine animal models" 12 : 7126-7135, 2006

18 Kane JF, "Effects of rare codon clusters on high-level expression of heterologous proteins in Escherichia coli" 6 : 494-500, 1995

19 Welch M, "Designing genes for successful protein expression" 498 : 43-66, 2011

20 Ikemura T, "Correlation between the abundance of Escherichia coli transfer RNAs and the occurrence of the respective codons in its protein genes: a proposal for a synonymous codon choice that is optimal for the E. coli translational system" 15 : 389-409, 1981

21 Sorensen MA, "Codon usage determines translation rate in Escherichia coli" 207 : 365-377, 1989

22 Anderson SGE, "Codon preferences in free living microorganisms" 54 : 198-210, 1990

23 Narum DL, "Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice" 69 : 7250-7253, 2001

24 Kim CH, "Codon optimization for highlevel expression of human erythropoietin (EPO) in mammalian cells" 199 : 293-301, 1997

25 Nagata T, "Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms" 261 : 445-451, 1999

26 Frelin L, "Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene" 11 : 522-533, 2004

27 Gustafsson C, "Codon bias and heterologous protein expression" 22 : 346-353, 2004

28 Roccasecca R, "Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2" 77 : 1856-1867, 2003

29 Qian W, "Balanced codon usage optimizes eukaryotic translational efficiency" 8 : e1002603-, 2012

30 Martinez-Donato G, "Antigenicity and immunogenicity of the hepatitis C virus envelope E2 protein" 23 : 60-63, 2006

31 Sharp PM, "An evolutionary perspective on synonymous codon usage in unicellular organisms" 24 : 28-38, 1986

32 Zolothukhin S, "A ‘‘humanized’’ green fluorescent protein cDNA adapted for high-level expression in mammalian cells" 70 : 4646-4654, 1996